ARAY

Accuray Incorporated [ARAY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ARAY Stock Summary

Top 10 Correlated Stocks

ARAY


In the News

01:31 29 Mar 2024 ARAY

Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment

Accuray (ARAY) announces the latest data that supports the use of its CyberKnife System in the treatment of recurrent prostate cancer with stereotactic body radiation therapy.

12:30 29 Mar 2024 ARAY

Here's Why You Should Retain Accuray (ARAY) Stock for Now

Accuray's (ARAY) solid product demand raises optimism about the stock.

12:36 29 Mar 2024 ARAY

Accuray (ARAY) Up 1.6% Since Last Earnings Report: Can It Continue?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

02:48 29 Mar 2024 ARAY

7 Screaming Stock Buys for Under $5

While most financial advisors will probably steer you away from under $5 stocks, they have their benefits. Just like in football – the American kind – you can't just run up the gut.

12:31 29 Mar 2024 ARAY

Three Reasons to Retain Accuray (ARAY) Stock in Your Portfolio

The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.

11:36 29 Mar 2024 ARAY

Accuray (ARAY) Q2 Earnings Lag Estimates, Gross Margin Contracts

Despite robust Services revenues, Accuray (ARAY) reports dismal second-quarter fiscal 2024 results.

10:03 29 Mar 2024 ARAY

Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript

07:36 29 Mar 2024 ARAY

Accuray (ARAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

10:21 29 Mar 2024 ARAY

Unveiling Accuray (ARAY) Q2 Outlook: Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Accuray (ARAY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

11:46 29 Mar 2024 ARAY

Accuray's (ARAY) CyberKnife S7 to Enhance Radiation Treatment

Accuray's (ARAY) latest generation CyberKnife S7 System is expected to boost the cancer treatment capabilities of the Providence Swedish Radiosurgery Center.

ARAY Financial details

Company Rating
Neutral
Market Cap
246.93M
Income
-14.55M
Revenue
447.48M
Book val./share
0.49
Cash/share
0.74
Dividend
-
Dividend %
-
Employees
1.02K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-39.47
Forward P/E
19
PEG
-2.76
P/S
0.59
P/B
5.27
P/C
3.34
P/FCF
-48.2
Quick Ratio
0.77
Current Ratio
1.66
Debt / Equity
4.24
LT Debt / Equity
3.98
-
-
EPS (TTM)
-0.15
EPS next Y
0.13
EPS next Q
-0.01
EPS this Y
66.67%
EPS next Y
-191.51%
EPS next 5Y
-230.4%
EPS last 5Y
-12.05%
Revenue last 5Y
1.34%
Revenue Q/Q
3.22%
EPS Q/Q
220.52%
-
-
-
-
SMA20
-5.28%
SMA50
-10.36%
SMA100
-5.64%
Inst Own
58.62%
Inst Trans
0.84%
ROA
-1%
ROE
-13%
ROC
0.02%
Gross Margin
35%
Oper. Margin
1%
Profit Margin
-1%
Payout
-
Shs Outstand
99.17M
Shs Float
93.29M
-
-
-
-
Target Price
7
52W Range
2.36-4.3
52W High
-38.25%
52W Low
+23.5%
RSI
42.25
Rel Volume
1.03
Avg Volume
411.78K
Volume
423.69K
Perf Week
-5%
Perf Month
-9.19%
Perf Quarter
-19.81%
Perf Half Y
-11.79%
-
-
-
-
Beta
1.448
-
-
Volatility
0.07%, 0.12%
Prev Close
1.65%
Price
2.47
Change
2.92%

ARAY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.844.264.44.824.82
Net income per share
-0.190.04-0.07-0.06-0.1
Operating cash flow per share
-0.34-0.020.43-0.030.17
Free cash flow per share
-0.39-0.060.4-0.080.03
Cash per share
0.891.21.2910.96
Book value per share
0.580.70.760.60.58
Tangible book value per share
-0.10.050.12-0.05-0.05
Share holders equity per share
0.580.70.760.60.58
Interest debt per share
2.022.672.42.492.32
Market cap
338.11M182.44M407.51M174.67M359.14M
Enterprise value
421.16M296.57M490.55M299.66M474.77M
P/E ratio
-20.5847.67-64.57-32.67-38.7
Price to sales ratio
0.810.481.030.410.8
POCF ratio
-11.41-124.210.58-72.7823.11
PFCF ratio
-9.96-35.1111.26-24.54125.66
P/B Ratio
6.782.915.923.286.69
PTB ratio
6.782.915.923.286.69
EV to sales
1.010.771.240.71.06
Enterprise value over EBITDA
722.424.9922.0636.78199.32
EV to operating cash flow
-14.21-201.8912.74-124.8630.55
EV to free cash flow
-12.4-57.0713.55-42.11166.12
Earnings yield
-0.050.02-0.02-0.03-0.03
Free cash flow yield
-0.1-0.030.09-0.040.01
Debt to equity
3.213.532.94.023.82
Debt to assets
0.360.450.420.450.43
Net debt to EBITDA
142.459.623.7315.3448.54
Current ratio
1.791.961.831.681.7
Interest coverage
-0.660.240.940.320.22
Income quality
1.8-0.38-6.10.45-1.67
Dividend Yield
00.010.0100
Payout ratio
00.59-0.48-0.05-0.02
Sales general and administrative to revenue
0.120.110.110.10.11
Research and developement to revenue
0.130.130.130.130.13
Intangibles to total assets
0.130.120.120.120.12
Capex to operating cash flow
0.152.54-0.061.97-0.82
Capex to revenue
-0.01-0.01-0.01-0.01-0.03
Capex to depreciation
-0.41-0.49-0.36-0.86-2.8
Stock based compensation to revenue
0.030.020.020.020.02
Graham number
1.570.821.10.91.14
ROIC
-0.050.010.070.020.01
Return on tangible assets
-0.040.01-0.01-0.01-0.02
Graham Net
-1.93-2.06-1.86-2.12-2.24
Working capital
151.89M174.37M160.41M142.03M139.4M
Tangible asset value
-8.58M4.41M10.45M-4.9M-4.23M
Net current asset value
-44.24M-70.66M-58.49M-68.77M-87.52M
Invested capital
3.213.532.94.023.82
Average receivables
88.94M100.74M87.48M89.9M84.61M
Average payables
24.63M26.34M21.3M25.4M32.54M
Average inventory
114.68M127.67M130.23M134.09M143.7M
Days sales outstanding
97.5285.478.6280.1860.98
Days payables outstanding
42.1336.2230.0142.3741.94
Days of inventory on hand
172.18210.69194.12192.34180.42
Receivables turnover
3.744.274.644.555.99
Payables turnover
8.6610.0812.168.618.7
Inventory turnover
2.121.731.881.92.02
ROE
-0.330.06-0.09-0.1-0.17
Capex per share
-0.05-0.04-0.03-0.05-0.14

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q2

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.221.241.231.081.1
Net income per share
-0.020.01-0.03-0.03-0.1
Operating cash flow per share
-0.190.260.09-0.09-0.05
Free cash flow per share
-0.210.240.01-0.1-0.06
Cash per share
0.720.930.930.80.74
Book value per share
0.550.570.560.530.49
Tangible book value per share
-0.07-0.04-0.04-0.07-0.1
Share holders equity per share
0.550.570.560.530.49
Interest debt per share
2.242.162.172.152.1
Market cap
195.83M283.7M371.31M262.63M276.71M
Enterprise value
335.49M399.66M486.94M390.62M406.17M
P/E ratio
-26.13118.41-36.32-22.11-7.19
Price to sales ratio
1.712.43.142.532.58
POCF ratio
-10.8711.5241.81-30.57-54.33
PFCF ratio
-10.0212.45438.9-27.12-43.63
P/B Ratio
3.785.196.925.165.81
PTB ratio
3.785.196.925.165.81
EV to sales
2.923.394.123.763.79
Enterprise value over EBITDA
124.02172.57-1.07K95.46-135.53
EV to operating cash flow
-18.6216.2354.83-45.47-79.75
EV to free cash flow
-17.1617.54575.58-40.34-64.04
Earnings yield
-0.010-0.01-0.01-0.03
Free cash flow yield
-0.10.080-0.04-0.02
Debt to equity
4.013.753.824.024.24
Debt to assets
0.440.430.430.430.42
Net debt to EBITDA
51.6350.07-253.0331.28-43.2
Current ratio
1.821.791.71.661.58
Interest coverage
0.591.02-0.150.76-1.36
Income quality
9.6141.11-3.472.890.53
Dividend Yield
0.010000
Payout ratio
-0.550-0.0300
Sales general and administrative to revenue
0.10.090.110.130.12
Research and developement to revenue
0.130.120.120.130.14
Intangibles to total assets
0.120.120.120.120.12
Capex to operating cash flow
0.09-0.07-0.90.130.25
Capex to revenue
-0.01-0.02-0.07-0.01-0.01
Capex to depreciation
-1.33-1.67-7.32-0.87-0.81
Stock based compensation to revenue
0.030.010.020.020.02
Graham number
0.50.280.580.61.04
ROIC
0.01000.02-0.02
Return on tangible assets
00-0.01-0.01-0.02
Graham Net
-2.18-2.08-2.16-2.24-2.2
Working capital
152.23M151.09M139.4M132.7M121.86M
Tangible asset value
-6.3M-3.36M-4.23M-6.88M-10.23M
Net current asset value
-80.08M-78.1M-87.52M-91.74M-97.53M
Invested capital
4.013.753.824.024.24
Average receivables
83.11M83.27M76.06M76.07M81.04M
Average payables
33.4M31.25M31.19M34.31M37.03M
Average inventory
154.14M153.12M147.87M147.56M152.6M
Days sales outstanding
69.9458.9756.8967.0271.1
Days payables outstanding
42.4532.537.6748.7449.43
Days of inventory on hand
195.14170.81162.05209.6195.84
Receivables turnover
1.291.531.581.341.27
Payables turnover
2.122.772.391.851.82
Inventory turnover
0.460.530.560.430.46
ROE
-0.040.01-0.05-0.06-0.2
Capex per share
-0.02-0.02-0.08-0.01-0.01

ARAY Frequently Asked Questions

What is Accuray Incorporated stock symbol ?

Accuray Incorporated is a US stock , located in Sunnyvale of Ca and trading under the symbol ARAY

Is Accuray Incorporated buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $7. The lowest prediction is $7 and the highest is $7

What is ARAY stock prediction ?

What is Accuray Incorporated stock quote today ?

Accuray Incorporated stock price is $2.47 today.

Is Accuray Incorporated stock public?

Yes, Accuray Incorporated is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap